Clinical trials
Active, not recruiting Ovarian Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| BioNTech Cell & Gene Therapies GmbH | 1 |
| Exelixis | 1 |
| Genmab | 1 |
| Hoffmann-La Roche | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Tesaro, Inc. | 1 |
| The Netherlands Cancer Institute | 1 |
| University Medical Center Nijmegen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 12 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Stomach Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Renal Cell | 2 |
| Colorectal Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Fallopian Tube Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Brain Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.